Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism BTK inhibitors(Tyrosine-protein kinase BTK inhibitors), HCK inhibitors(Tyrosine-protein kinase HCK inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Preclinical | US | 19 May 2023 |